English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 23 Help

Selected(0)Clear Items/Page:    Sort:
Education, gender, and frequent pain among middle-aged and older adults in the United States, England, China, and India Journal article
Li, Chihua, Liu, Chunyu, Ye, Chenfei, Lian, Zi, Lu, Peiyi. Education, gender, and frequent pain among middle-aged and older adults in the United States, England, China, and India[J]. Pain, 2024.
Authors:  Li, Chihua;  Liu, Chunyu;  Ye, Chenfei;  Lian, Zi;  Lu, Peiyi
Favorite | TC[Scopus]:1  IF:5.9/7.1 | Submit date：2024/10/10
Cross-national Study  Education  Frequent Pain  Gender  Socioeconomic Status  
TRADUÇÃO DE METÁFORAS VERBO-PICTÓRICAS PARA PÁGINAS WEB DO SMARTPHONE HUAWEI P40 PRO À LUZ DA TEORIA DE NECESSIDADES Journal article
Sun, Yuqi, Ye, Zi. TRADUÇÃO DE METÁFORAS VERBO-PICTÓRICAS PARA PÁGINAS WEB DO SMARTPHONE HUAWEI P40 PRO À LUZ DA TEORIA DE NECESSIDADES[J]. Cadernos de Tradução, 2023, 43(3), 272-302.
Authors:  Sun, Yuqi;  Ye, Zi
Favorite | TC[Scopus]:1 | Submit date：2023/08/24
TRADUÇÃO DE METÁFORAS VERBO-PICTÓRICAS PARA PÁGINAS WEB DO SMARTPHONE HUAWEI P40 PRO À LUZ DA TEORIA DE NECESSIDADES Journal article
Sun, Yuqi, Ye, Zi. TRADUÇÃO DE METÁFORAS VERBO-PICTÓRICAS PARA PÁGINAS WEB DO SMARTPHONE HUAWEI P40 PRO À LUZ DA TEORIA DE NECESSIDADES[J]. Cadernos de Tradução, 2023.
Authors:  Sun, Yuqi;  Ye, Zi
Favorite |  | Submit date：2024/08/30
Tradução  Metáfora Conceitual  Metáfora Verbo-pictórica  Teoria Das Necessidades  PublicidaDes De Páginas Web  
Limonoids from the roots of Melia azedarach and their anti-inflammatory activity Journal article
Song, Min, Luo, Hui Juan, Li, Zi Wei, Qiu, Ling, Zhao, Yu Xin, He, Cheng Wei, Zhang, Xiao Qi, Ye, Wen Cai, Lin, Li Gen, Zhang, Qing Wen. Limonoids from the roots of Melia azedarach and their anti-inflammatory activity[J]. Phytochemistry, 2023, 216, 113869.
Authors:  Song, Min;  Luo, Hui Juan;  Li, Zi Wei;  Qiu, Ling;  Zhao, Yu Xin; et al.
Favorite | TC[WOS]:2 TC[Scopus]:3  IF:3.2/3.4 | Submit date：2024/01/02
1l-1β  Anti-inflammatory Activity  Limonoids  MeL.a Azedarach L.  Nlrp3  
Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10 Journal article
Huang, Mu Yang, Chen, Yu Chi, Lyu, Wen Yu, He, Xin Yu, Ye, Zi Han, Huang, Can Yu, He, Xin Ling, Chen, Xiuping, Chen, Xiaobing, Zhang, Baoxian, Kai, Guoyin, Zhang, Xiaolei, Li, Ting, Huang, Mingqing, Lu, Jin Jian. Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10[J]. Pharmacological Research, 2023, 198, 106988.
Authors:  Huang, Mu Yang;  Chen, Yu Chi;  Lyu, Wen Yu;  He, Xin Yu;  Ye, Zi Han; et al.
Favorite | TC[WOS]:11 TC[Scopus]:14  IF:9.1/9.0 | Submit date：2024/01/02
Combination Treatment  Ginsenoside Rh2  Pd-1/pd-l1  t Cells  Tumor Microenvironment  
To go or not to go? Exhibition attendees’ risk perception of COVID-19: Evidence from three Asian regions Journal article
Chan,Zi Xuan, Ye,Huiyue, Li,Junhua, Wei,Lexi Dan. To go or not to go? Exhibition attendees’ risk perception of COVID-19: Evidence from three Asian regions[J]. Journal of Convention and Event Tourism, 2023, 24(4), 318-340.
Authors:  Chan,Zi Xuan;  Ye,Huiyue;  Li,Junhua;  Wei,Lexi Dan
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:1.7/1.9 | Submit date：2023/08/03
Covid-19  Elaboration Likelihood Model (Elm)  Exhibition Industry  Risk Perception  Travel Behavior  
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Review article
2023
Authors:  Ye, Zi Han;  Yu, Wei Bang;  Huang, Mu Yang;  Chen, Jun;  Lu, Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date：2023/05/02
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Journal article
Ye,Zi Han, Yu,Wei Bang, Huang,Mu Yang, Chen,Jun, Lu,Jin Jian. Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives[J]. Acta Pharmaceutica Sinica B, 2023, 13(4), 1467-1487.
Authors:  Ye,Zi Han;  Yu,Wei Bang;  Huang,Mu Yang;  Chen,Jun;  Lu,Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date：2023/08/03
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
Clinical Benefit of First-Line Programmed Death-1 Antibody Plus Chemotherapy in Low Programmed Cell Death Ligand 1-Expressing Esophageal Squamous Cell Carcinoma: A Post Hoc Analysis of JUPITER-06 and Meta-Analysis Journal article
Wu, Hao Xiang, Pan, Yi Qian, He, Ye, Wang, Zi Xian, Guan, Wen Long, Chen, Yan Xing, Yao, Yi Chen, Shao, Ning Yi, Xu, Rui Hua, Wang, Feng. Clinical Benefit of First-Line Programmed Death-1 Antibody Plus Chemotherapy in Low Programmed Cell Death Ligand 1-Expressing Esophageal Squamous Cell Carcinoma: A Post Hoc Analysis of JUPITER-06 and Meta-Analysis[J]. Journal of Clinical Oncology, 2023, 41(9), 1735-1746.
Authors:  Wu, Hao Xiang;  Pan, Yi Qian;  He, Ye;  Wang, Zi Xian;  Guan, Wen Long; et al.
Favorite | TC[WOS]:30 TC[Scopus]:32  IF:42.1/37.4 | Submit date：2023/04/03
Pembrolizumab  Placebo  Camrelizumab  Nivolumab  Survival  Efficacy  Therapy  Safety  Chemo  
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer Journal article
Wei-Bang Yu, Yu-Chi Chen,, Can-Yu Huang, Zi-Han Ye, Wei Shi, Hong Zhu, Jia-Jie Shi, Jun Chen, Jin-Jian Lu. CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer[J]. Frontiers of Medicine, 2022, 17(1), 105-118.
Authors:  Wei-Bang Yu;  Yu-Chi Chen,;  Can-Yu Huang;  Zi-Han Ye;  Wei Shi; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.9/5.4 | Submit date：2023/01/30
Adcp  Anti-cd47 Antibody  Combination Strategy  Egfr  Osimertinib